[8] In 2024, the FDA also approved Wegovy to reduce the risk of cardiovascular death, heart attack, and stroke in adults with established cardiovascular disease and either obesity or overweight
However, in a large study involving people with diabetes who had no comorbidities, GLP-1 RAs were not shown to increase the risk of developing pancreatitis at any time point up through 5 years of use.[ref][ref][ref][ref] The Cleveland Clinic now counsels that GLP-1 RA patients should be screened for pancreatitis risk factors, and a lower dose should be used to reduce the risk of pancreatitis.[ref] Related article : Pancreatitis and Genetic Risk Factors Gastroparesis: Case reports tie semaglutide to a risk of gastroparesis (very slow stomach emptying)
Step One Starting Well aims to (i) enhance mutual understanding of the cognitive-behavioral mechanisms that sustain a patients BED, (ii) reduce preoccupation with weight, (iii) decrease the frequency of binge-eating episodes, and (iv) promote the adoption of an active lifestyle
Not only will this be more painful, but it could also cause bruising, itching and soreness that lasts longer
There is a pregnancy exposure registry for women who use semaglutide intended for weight management (Wegovy) during pregnancy
What do units mean on an insulin syringe